Clinical trial
Waxing and Waning of Serum SARS CoV 2 IgG Level: A Prospective Study
NCT04568850 is registered in ClinicalTrials.gov with Lahore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Waxing and Waning of Serum SARS CoV 2 IgG Level: A Prospective Study
- Lead sponsor
- Lahore General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2020
- Completion date
- February 28, 2022
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
covid19